Click on image to view larger version.

Figure 6 Of the 22 Patients Treated With Iloprost, 9 Were Transitioned From IV Prostanoids With 8 Tolerating the Transition

In 13 children, iloprost was used as add-on or de novo therapy. Of the 13 patients, 6 remain on therapy and 4 required transition to intravenous (IV) prostanoids. Two patients discontinued iloprost, owing to airways reactivity, and 1 patient died. SQ = subcutaneous.